ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) Net margin 2015–2024
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) net profit margin by fiscal year — reported net income divided by reported revenue.
-39.8%FY2024 · since FY2015: -223.5% → -39.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -39.8% | +149.1 pp |
| FY2023 | -188.9% | +420.6 pp |
| FY2022 | -609.5% | +1961.5 pp |
| FY2021 | -2571.0% | +715.8 pp |
| FY2020 | -3286.8% | +8938.2 pp |
| FY2019 | -12225.0% | -12064.5 pp |
| FY2018 | -160.5% | +24.9 pp |
| FY2017 | -185.4% | +318.8 pp |
| FY2016 | -504.1% | -280.7 pp |
| FY2015 | -223.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice